Insulin prices spiked in the 2010s, sparking criticism from lawmakers and consumer advocates.
California is suing drugmakers and pharmacy benefits managers (PBMs), accusing them of colluding to drive up the cost of insulin, the life-saving drug that millions of diabetics rely on but which is so expensive that many consumers struggle to afford it, even those covered by health plans. Similar suits were
The cost of insulin has been rising steadily in the United States – up 11 percent annually in recent years – reaching an average annual cost of $6,000 per patient. One result is obvious: many patients, as many as one-fourth by some estimates, are cutting back or even going without their